Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.
Mathiesen ER, Ali N, Anastasiou E, Cypryk K, de Valk HW, Dores JM, Dunne FP, Ekelund M, Durán García S, Hanaire H, Husemoen LLN, Ivanisevic M, Kempe HP, Nordsborg RB, McCance DR.
Mathiesen ER, et al.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7992-8000. doi: 10.1080/14767058.2021.1940132. Epub 2021 Jun 28.
J Matern Fetal Neonatal Med. 2022.
PMID: 34182866